老年重症幸存者出院后新发与持续性镇静药物处方:一项基于人群的队列研究
该基于人群的队列研究纳入加拿大安大略省2003-2019年≥66岁、住院前≤6个月内未填写过镇静药处方的ICU幸存者共250,428例(平均年龄76岁,61%男性)。6.1%(15,277例)在出院≤7天内填写了新镇静药处方,各医院间差异从2%(95%CI 1-3)到44%(95%CI 3-57);3.4%(8,458例)填写了持续性镇静药处方。出院至长期护理机构(aOR 4.00)、接受老年科(aOR 1.95)或精神科(aOR 2.76)会诊、有创通气(aOR 1.59)、ICU住院≥7天(aOR 1.50)与新处方相关;医院间残余异质性(adjusted median OR 1.43)强于Charlson合并症指数或脓毒症。作者认为出院时新处方存在潜在优化空间,包括药物审查与核对。
要点
- 在250,428例未用过镇静药的老年ICU幸存者中,6.1%(15,277例)在出院≤7天内填写了新镇静药处方,3.4%(8,458例)填写了持续性处方(≤6个月)。
- 新镇静药处方率在各医院间差异显著,从2%(95%CI 1-3)到44%(95%CI 3-57)。
- 出院至长期护理机构(aOR 4.00;95%CI 3.72-4.31)与新镇静药处方关联最强,其次为精神科会诊(aOR 2.76;95%CI 2.62-2.91)、老年科会诊(aOR 1.95;95%CI 1.80-2.10)、有创通气(aOR 1.59;95%CI 1.53-1.66)和ICU住院≥7天(aOR 1.50;95%CI 1.42-1.58)。
- 医院间残余异质性(adjusted median OR 1.43;95%CI 1.35-1.49)与新镇静药处方的关联强于Charlson合并症指数评分或脓毒症。
- 持续性镇静药处方的相关因素与新处方相似,另外女性(subdistribution HR 1.07;95%CI 1.02-1.13)和既往多重用药(subdistribution HR 0.88;95%CI 0.80-0.93)也与持续性用药相关。
适用人群与场景
- 加拿大安大略省2003-2019年≥66岁的ICU幸存者,且住院前≤6个月内未填写过镇静药处方(未用过镇静药)。
研究设计与关键结果
- 研究类型:基于人群的队列研究;样本量250,428例;人群为≥66岁未用过镇静药的ICU幸存者(平均年龄76岁,61%男性)。
- 主要终点:出院≤7天内填写新镇静药处方15,277例(6.1%),各医院间差异从2%(95%CI 1-3)到44%(95%CI 3-57)。
- 持续性镇静药处方(≤6个月)8,458例(3.4%)。
- 与新镇静药处方相关的调整因素:出院至长期护理机构aOR 4.00(95%CI 3.72-4.31)、精神科会诊aOR 2.76(95%CI 2.62-2.91)、老年科会诊aOR 1.95(95%CI 1.80-2.10)、有创通气aOR 1.59(95%CI 1.53-1.66)、ICU住院≥7天aOR 1.50(95%CI 1.42-1.58)。
- 医院间残余异质性adjusted median OR 1.43(95%CI 1.35-1.49),其与新镇静药处方的关联强于Charlson合并症指数评分或脓毒症。
- 与持续性镇静药处方相关的因素与新处方相似,另外女性subdistribution HR 1.07(95%CI 1.02-1.13),既往多重用药subdistribution HR 0.88(95%CI 0.80-0.93)。
证据类型、等级与局限
- 证据类型:基于人群的队列研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为出院时新镇静药处方存在潜在优化空间,包括药物审查与核对。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: ICU survivors often have complex care needs and can experience insufficient medication reconciliation and polypharmacy. It is unknown which ICU survivors are at risk of new sedative use posthospitalization.
RESEARCH QUESTION: For sedative-naive, older adult ICU survivors, how common is receipt of new and persistent sedative prescriptions, and what factors are associated with receipt?
STUDY DESIGN AND METHODS: This population-based cohort study included ICU survivors aged ≥ 66 years who had not filled sedative prescriptions within ≤ 6 months before hospitalization (sedative-naive) in Ontario, Canada (2003-2019). Using multilevel logistic regression, demographic, clinical, and hospital characteristics and their association with new sedative prescription within ≤ 7 days of discharge are described. Variation between hospitals was quantified by using the adjusted median OR. Factors associated with persistent prescriptions (≤ 6 months) were examined with a multivariable proportional hazards model.
RESULTS: A total of 250,428 patients were included (mean age, 76 years; 61% male). A total of 15,277 (6.1%) filled a new sedative prescription, with variation noted across hospitals (2% [95% CI, 1-3] to 44% [95% CI, 3-57]); 8,458 (3.4%) filled persistent sedative prescriptions. Adjusted factors associated with a new sedative included: discharge to long-term care facility (adjusted OR [aOR], 4.00; 95% CI, 3.72-4.31), receipt of inpatient geriatric (aOR, 1.95; 95% CI, 1.80-2.10) or psychiatry (aOR, 2.76; 95% CI, 2.62-2.91) consultation, invasive ventilation (aOR, 1.59; 95% CI, 1.53-1.66), and ICU length of stay ≥ 7 days (aOR, 1.50; 95% CI, 1.42-1.58). The residual heterogeneity between hospitals (adjusted median OR, 1.43; 95% CI, 1.35-1.49) had a stronger association with new sedative prescriptions than the Charlson Comorbidity Index score or sepsis. Factors associated with persistent sedative use were similar with the addition of female subjects (subdistribution hazard ratio, 1.07; 95% CI, 1.02-1.13) and pre-existing polypharmacy (subdistribution hazard ratio, 0.88; 95% CI, 0.80-0.93).
INTERPRETATION: One in 15 sedative-naive, older adult ICU survivors filled a new sedative within ≤ 7 days of discharge; more than one-half of these survivors filled persistent prescriptions. New prescriptions at discharge varied widely across hospitals and represent the potential value of modifying prescription practices, including medication review and reconciliation.
参考来源
- Burry LD, Bell CM, Hill A, et al. New and Persistent Sedative Prescriptions Among Older Adults Following a Critical Illness: A Population-Based Cohort Study. Chest. 2023. PMID: 36610663. doi:10.1016/j.chest.2022.12.033
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。